Lithium treatment, nephrogenic diabetes insipidus and the risk of hypernatraemia: a retrospective cohort study

Bj？rn Forssén,Michael Ott,Ursula Werneke

Trends in the scientific literature on atypical antipsychotic drugs in the United Kingdom: a bibliometric study

Cecilio álamo,Derek K. Tracy,F. Javier Povedano-Montero,Francisco López-Mu？oz,Gabriel Rubio,Javier García-Pacios,Josefien Breedvelt,Ma Poveda Fernández-Martín

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques

Fariba Jamshidi,Julie K. Mannchen,Michael Ott,Ursula Werneke

Genetic risk factors for eating disorders: an update and insights into pathophysiology

Carol Kan,Hubertus Himmerich,Janet Treasure,Jessica Bentley

Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders

Lex Wunderink

Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance

Andreas Sotiriou,Emma Tay,Garry G. Graham,Kay Wilhelm,Leone Snowden,Richard O. Day

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature

Flávia L. Osório,Giordano N. Rossi,Jaime E. C. Hallak,José Alexandre S. Crippa,José Carlos Bouso,Juliana M. Rocha,Rafael G. dos Santos

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine

Fatima Motiwala,Hina Saeed,Hiren Patel,Muhammad Khalid Zafar,Namrata Jannareddy,Rikinkumar S. Patel,Zeeshan Mansuri

What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?

Petr Potmě？il

The relationship between nicotine and psychosis

Harriet Quigley,James H. MacCabe

The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders

Arne Reimers,Hanna Ljung

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal？ Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil

Angela Wehr,David P. Walling,John Sonnenberg,Lisa von Moltke,Marjie L. Hard,Sarah Farwick,Yangchun Du

Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis

Allan H. Young,Anthony J. Cleare,James M. Stone,Syed Yawar Zaidi,Viktoriya Nikolova

Trim the fat: the role of omega-3 fatty acids in psychopharmacology

Madeeha Nasir,Michael H. Bloch

Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics

Chirag Vegad,Daniel Sedough-Abbasian,David M. Taylor,Oscar Chak,Sharanjeet Punny,Shubhra Mace

Treatment of psychoses in patients with epilepsy: an update

Marco Mula,Niruj Agrawal

The association between hormones and antipsychotic use: a focus on postpartum and menopausal women

Alexandre González-Rodríguez,Mary V. Seeman

The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder

Brigitte Vanle,Devvrat Malhotra,Jonathan Dang,Steven S. Clevenger,Waguih William IsHak

Frontotemporal dementia: latest evidence and clinical implications

Deena Tampi,Juan Joseph Young,Mallika Lavakumar,Rajesh R. Tampi,Silpa Balachandran

Treatment of adult ADHD: a clinical perspective

Josh Geffen,Kieran Forster

Assessment and management of sexual dysfunction in the context of depression

Jeffrey R. Hankey,Pratap R. Chokka

Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation

Brittany E. Manobianco,Dimy Fluyau,Neelambika Revadigar

Rethinking the spectrum of mood disorders: implications for diagnosis and management – Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France

Allan H. Young,Peter M. Haddad,Roger S. McIntyre

Naming the drugs we use: neuroscience-based nomenclature, a helpful innovation

Sue Wilson

Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy

Hiroto Ito,Kotaro Hatta,Naoya Sugiyama

Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study

Eibert R. Heerdink,Helga Gardarsdottir,Heshu Abdullah-Koolmees,Judith Vuyk,Kamjar Elmi,Laurette E. Goedhard,Lennart J. Stoker,Lotte A. Minnema,Toine C. G. Egberts

Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment

Anna Cz？onkowska,Janusz K. Rybakowski,Karolina Dzie？yc,Petr Dusek,Tomasz Litwin,Tomasz Szafrański

Haloperidol decanoate long-acting injection (HDLAI): Results of a 1-year mirror-image study

David Taylor,Maria O’Hagan,Olubanke Dzahini,Shubhra Mace

Dilemmas in the treatment of early-onset first-episode psychosis

Daniel Hayes,Marinos Kyriakopoulos

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial

Carol Paton,David P. Osborn,Hemant Bagalkote,Khalid Iqbal,Louise Marston,Mariwan Husni,Patrick Keown,Pavel Fridrich,Peter M. Haddad,Raj Kumar,Rameez Zafar,Thomas R.E. Barnes,Tim Amos,Verity Leeson,Vineet Singh,Zachary Fitzgerald

TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel

Baybars Veznedaroglu,Erdal Isik,Nesrin Dilbaz,Ozcan Uzun

Epidemiology and risk factors for bipolar disorder

Steven Marwaha,Tobias A. Rowland

Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in Quebec

Emmanuel Stip,Jean Lachaine

The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses

Christoph U. Correll,Peter M. Haddad

Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective

Stephen M. Lawrie

First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse

David Taylor,James M. Stone,Paul D. Morrison,Simon Roux

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

Elisa Brietzke,Mehala Subramaniapillai,Rodrigo B. Mansur,Roger C. Ho,Roger S. McIntyre,Samantha J. Yim,Yena Lee

Corrigendum

Novel developments in Therapeutic Advances in Psychopharmacology

Hemi Malkki,Professor David Taylor

Clozapine, HIV and neutropenia: a case report

David O’Flynn,David Taylor,Eromona Whiskey

Medication nonadherence in bipolar disorder: a narrative review

Ibrahim Jawad,Peter M. Haddad,Peter S. Talbot,R. Hamish McAllister-Williams,Stuart Watson

Effectiveness of paliperidone long-acting injection in clinical practice

Elan Haf Ward,Kathryn Norris,Paul Nicholas Deslandes,Robert David Sewell

Neuromodulation for the treatment of eating disorders and obesity

Andres M. Lozano,Darrin J. Lee,Gavin J.B. Elias

Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013

Binu Jacob,Claire de Oliveira,David Rudoler,Juveria Zaheer,Paul Kurdyak,Simon J.C. Davies

The antipsychotic landscape: dopamine and beyond

Paul D. Morrison,Robin M. Murray

A prospective year-long follow-up of lurasidone use in clinical practice: factors predicting treatment persistence

David Taylor,Ian J. Osborne,Shubhra Mace

Acetylcholinesterase inhibitors in treatment-resistant psychotic depression

Chris Smart,David Andrew Cousins,Hamish McAllister-Williams

Alternatives to ketamine in depression: state-of-the-art and future perspectives

James M. Stone,Luke A. Jelen,Sinead King

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity

Amir Krivoy,Erna Henriksdottir,Lilla Porffy,Penelope Lowe,Sukhwinder S. Shergill,Whiskey Eromona

Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service

Andrew Shaker,Rowena Jones